-
x
x
bid
ask
03:17 AM


sentiment
day range
52 week range
Prev Close
Open
Low
High
Volume0.00
Avg. Volume0.00
Market Cap0.00
Inst. Own
Beta
Short Ratio
Div & Yield /
EPS
P/E
1yr Target
50day MA
200day MA
^DJI
Dow Jones Industrial Average
33963.80
05:35 PM
-
106.60
0.31%
^IXIC
NASDAQ Composite
13211.80
05:15 PM
-
12.20
0.09%
^GSPC
S&P 500
4320.06
05:35 PM
-
9.94
0.23%
AAPL
174.95
+0.16 (0.09%)
Apple Inc.
174.79
9 @ 04:00 PM
9 x 174.93
9 x 175.10
+
0.86
0.49%
GOOG
131.44
+0.19 (0.15%)
Alphabet Inc.
131.25
9 @ 04:00 PM
8 x 131.50
9 x 131.63
-
0.11
0.08%
AMZN
129.30
+0.18 (0.14%)
Amazon.com, Inc.
129.12
9 @ 04:00 PM
8 x 129.27
10 x 129.28
-
0.21
0.16%
MSFT
316.81
-0.20 (0.06%)
Microsoft Corporation
317.01
11 @ 04:00 PM
8 x 316.81
13 x 317.01
-
2.52
0.79%
BABA
88.50
+0.20 (0.23%)
Alibaba Group Holding Limited
88.30
8 @ 04:01 PM
8 x 88.50
8 x 88.58
+
4.19
4.98%
NFLX
379.65
-0.16 (0.04%)
Netflix, Inc.
379.81
10 @ 04:00 PM
9 x 379.82
11 x 380.43
-
4.34
1.13%
TSLA
244.16
-0.72 (0.29%)
Tesla, Inc.
244.88
11 @ 04:00 PM
9 x 243.86
13 x 244.16
-
10.82
4.23%
NVDA
415.74
-0.36 (0.09%)
NVIDIA Corporation
416.10
21 @ 04:00 PM
11 x 415.58
31 x 415.90
+
5.93
1.45%
AMD
96.08
-0.12 (0.12%)
Advanced Micro Devices, Inc.
96.20
13 @ 04:00 PM
14 x 96.01
12 x 96.13
+
0.09
0.09%
MU
68.89
+0.01 (0.01%)
Micron Technology, Inc.
68.88
14 @ 04:00 PM
14 x 68.85
13 x 68.95
+
0.98
1.44%
SPY
430.69
+0.27 (0.06%)
SPDR S&P 500 ETF Trust
430.42
31 @ 04:00 PM
31 x 430.52
30 x 430.80
-
0.97
0.22%
TQQQ
35.68
+0.05 (0.15%)
ProShares UltraPro QQQ
35.63
35 @ 04:00 PM
40 x 35.68
29 x 35.73
+
0.02
0.07%
BRK-A
544000.00
-2215.00 (0.41%)
Berkshire Hathaway Inc.
546215.00
10 @ 04:00 PM
9 x 544500.00
10 x 547042.00
-
4815.00
0.87%
Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
News
...
Deep Track Capital, LP Acquires New Stake in Terns Pharmaceuticals Inc | gurufocus.com • |
Astellas Pharma CEO Says Confident of Iveric Bio Drug Approval | youtube.com • |
Iveric Bio stock surges on Astellas Pharma takeover deal | proactiveinvestors.com • |
Biotech Buying Bonanza: Iveric Bio Snags $5.9 Billion Deal From Astellas Pharma | investors.com • |
Iveric Bio Stock Surges. It's Being Bought by Astellas for $5.9 Billion. | barrons.com • |
Japan's Astellas Pharma to buy Iveric Bio in deal worth $5.9 billion | marketwatch.com • |
Profile
...
IVERIC bio, Inc., a biopharmaceutical company, focuses on the discovery and development of novel treatments for retinal diseases with unmet medical needs. The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; GATHER2 that is in Phase 3 clinical trial for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD); and STAR or OPH2005 that is in Phase 2b clinical trial for the treatment of autosomal recessive Stargardt disease. Its preclinical product candidatures include IC-500, a high temperature requirement A serine peptidase 1 protein inhibitors for the treatment of GA and other age-related retinal diseases. The company also develops OPH2001 that has completed Phase 1/2a clinical trial of various doses of avacincaptad pegol (ACP) administered as a monotherapy for the treatment of GA; OPH2000, which has completed Phase 1/2a clinical trial of various doses of ACP administered in combination with Lucentis for the treatment of wet AMD; OPH2007 that has completed Phase 2a clinical trial for the treatment of wet AMD; and OPH2002, which has completed Phase 2a clinical trial for the treatment of idiopathic polypoidal choroidal vasculopathy. In addition, its minigene programs comprises miniCEP290 program for LCA10; miniABCA4 Program for STGD1; and miniUSH2A Program for usher syndrome type 2A-Related inherited retinal diseases (IRDs). The company was formerly known as Ophthotech Corporation and changed its name to IVERIC bio, Inc. in April 2019. The company was incorporated in 2007 and is based in Parsippany, New Jersey. As of July 11, 2023, IVERIC bio, Inc. operates as a subsidiary of Astellas US Holding, Inc.
Earning
...
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-07-25 | 2023-06 | -0.49 | N/A | N/A | N/A |
2023-05-10 | 2023-03 | -0.44 | N/A | N/A | N/A |
2023-03-01 | 2022-12 | -0.37 | N/A | N/A | N/A |
2022-11-03 | 2022-09 | -0.4 | N/A | N/A | N/A |
2022-07-26 | 2022-06 | -0.31 | N/A | N/A | N/A |
2022-05-04 | 2022-03 | -0.29 | N/A | N/A | N/A |
Upgrade / Downgrade
...
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-05-08 | TD Cowen | Downgrade | Outperform | Market Perform |
2023-05-04 | Baird | Downgrade | Outperform | Neutral |
2023-05-03 | UBS | Downgrade | Buy | Neutral |
2023-05-02 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
2023-05-01 | Wedbush | Downgrade | Outperform | Neutral |
2023-05-01 | Guggenheim | Downgrade | Buy | Neutral |
Insider Holder
...
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-05-10 | BLUMENKRANZ MARK S | Director | 32.09K | Conversion of Exercise of derivative security |
2023-05-10 | BOLTE AXEL | Director | 22.09K | Conversion of Exercise of derivative security |
2023-06-25 | CARROLL DAVID FRANCIS | Chief Financial Officer | 44.15K | Stock Gift |
2023-06-27 | GIBNEY ANTHONY S. | Officer | 40.29K | Stock Gift |
2023-05-10 | GRAVES ADRIENNE L | Director | 22.09K | Conversion of Exercise of derivative security |
2023-05-10 | HENDERSON JANE | Director | 22.09K | Conversion of Exercise of derivative security |
Institution Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-03-30 | Vanguard Group, Inc. (The) | 13.66M | 545.77M | 9.92% |
2023-03-30 | Blackrock Inc. | 10.13M | 404.63M | 7.35% |
2023-03-30 | Price (T.Rowe) Associates Inc | 6.81M | 272.17M | 4.94% |
2023-03-30 | Avoro Capital Advisors LLC | 6.80M | 271.66M | 4.94% |
2023-03-30 | Deep Track Capital, LP | 6.50M | 259.68M | 4.72% |
2023-03-30 | State Street Corporation | 5.62M | 224.69M | 4.08% |
Fund Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-12-30 | Vanguard Total Stock Market Index Fund | 4.06M | 162.20M | 2.96% |
2023-02-27 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 3.38M | 135.05M | 2.47% |
2023-02-27 | iShares Russell 2000 ETF | 2.96M | 118.24M | 2.16% |
2022-12-30 | Smallcap World Fund | 2.16M | 86.46M | 1.58% |
2022-12-30 | Price (T.Rowe) Health Sciences Fund | 1.84M | 73.33M | 1.34% |
2022-12-30 | Vanguard Small-Cap Index Fund | 1.73M | 69.04M | 1.26% |
This topic has been deleted. Only users with topic management privileges can see it.
-
Take profits and head too $OCGN for there eye and Vaxx run next…
-
$ISEE me shorting this one……it’s going down
-
Only the big dogs know. Us retail slobs have to guess on the up one no news.
-
Good luck on the cash secured puts. I hope you don’t get burned. Almost too good to be true.
-
Something is Brewing.
-
Will it touch 11 or 9 first?
-
Why is this selling off so hard?
-
-
Iveric Bio stock surges on Astellas Pharma takeover deal
proactiveinvestors.com • -
Japan's Astellas Pharma to buy Iveric Bio in deal worth $5.9 billion
marketwatch.com • -
These Are the Top 10 Holdings of David Kim
247wallst.com • -
Why Is Iveric Bio (ISEE) Stock Up 25% Today?
investorplace.com • -
IVERIC bio, Inc. (ISEE) Q3 2022 Earnings Call Transcript
seekingalpha.com • -
Iveric Bio to Present at Upcoming Investor Conferences
businesswire.com • -
Why Is Iveric Bio (ISEE) Stock Up 56% Today?
investorplace.com • -
7 Cheap Biotech Stocks to Buy Now
investorplace.com • -
Trial Results Set to Make or Break Small-Cap Pharma Stocks
gurufocus.com • -
IVERIC bio: A First Take
seekingalpha.com • -
Biopharmaceutical Stocks: The Bottoming Process Is Playing Out
seekingalpha.com • -
Iveric Bio to Present at the UBS Global Healthcare Conference 2022
businesswire.com • -
Wednesdays With Wedbush: 3 Smid-Cap Biotech Stock Picks
benzinga.com • -
7 A-Rated Biotechs to Buy for the Long Run
investorplace.com • -
Apellis' Loss Is Iveric Bio's Gain In Lucrative Eye Disease Field
seekingalpha.com • -
ISEE Stock: Why It Significantly Increased Yesterday
pulse2.com • -
Why IVERIC Bio Shares Are Soaring Today
benzinga.com • -
Why Are Iveric Bio Shares Surging In Premarket Friday?
benzinga.com • -
New Strong Sell Stocks for August 18th
zacks.com • -
Small-Cap Stocks To Watch After CYTK Sheds Spotlight On Biotech
pennystocks.com • -
Iveric Bio Appoints Christopher Simms as Chief Commercial Officer
businesswire.com • -
IVERIC bio (ISEE) Enters Overbought Territory
zacks.com • -
IVERIC bio, Inc. Announces Proposed Offering of Common Stock
businesswire.com • -
IVERIC bio Stock Increased 11.87%: Why It Happened
pulse2.com • -
New Strong Sell Stocks for April 26th
zacks.com • -
New Strong Sell Stocks for April 21st
zacks.com • -
New Strong Sell Stocks for April 6th
zacks.com • -
David R. Guyer, MD to Step Down from Iveric Bio Board to Rejoin Venture Fund
businesswire.com • -
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com • -
Iveric Bio to Present at the Cowen 41st Annual Health Care Conference
businesswire.com • -
4 Health Stocks Stonepine Capital Loves (1 Has Gained 233% Since September 29)
insidermonkey.com • -
IVERIC bio to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
finance.yahoo.com • -
IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com • -
Worsening eye sight doesn't stop for Covid, neither did we
irishtimes.com • -
Did Hedge Funds Make The Right Call On IVERIC bio, Inc. (ISEE) ?
finance.yahoo.com • -
Two Sigma Advisers LP Has $258,000 Stock Position in IVERIC bio Inc (NASDAQ:ISEE)
thelincolnianonline.com • -
17,273 Shares in IVERIC bio Inc (NASDAQ:ISEE) Purchased by JPMorgan Chase & Co.
thelincolnianonline.com • -
Moving Average Crossover Alert: IVERIC bio
finance.yahoo.com • -
Iveric's Trial Progress And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com • -
Iveric Bio: Pick Up Post-Fundraising Low And Hold For Good News
seekingalpha.com • -
Two Sigma Investments LP Invests $675,000 in IVERIC bio Inc (NASDAQ:ISEE)
thelincolnianonline.com • -
822,050 Shares in IVERIC bio Inc (NASDAQ:ISEE) Acquired by Deutsche Bank AG
thelincolnianonline.com • -
NOVARTIS AG : Buy rating from Oddo | MarketScreener
marketscreener.com • -
IVERIC bio Inc (NASDAQ:ISEE) Receives Consensus Rating of “Hold” from Analysts
thelincolnianonline.com • -
Specsavers stores have reopened for eye tests across Cambridgeshire
cambridge-news.co.uk • -
Is IVERIC bio, Inc. (ISEE) Going to Burn These Hedge Funds?
finance.yahoo.com •